Source:http://linkedlifedata.com/resource/pubmed/id/15121297
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
15-16
|
pubmed:dateCreated |
2004-5-3
|
pubmed:abstractText |
We have developed an experimental model of vaccination against the infection with the protozoa Trypanosoma cruzi, the agent of Chagas disease in Latin America. Vaccination was performed with Trypanosoma rangeli, a non-pathogenic protozoa sharing many antigens with T. cruzi. It strongly protected BALB/c mice, sharply reducing parasitaemia and mortality rate of the acute T. cruzi infection. The aim of the present work was to complete our previous study on the production of IFN-gamma and IL-10 in this vaccination model by investigating the production of IL-12p35 and p40, IL-18, TNF, TNF soluble receptors (sTNFR), and nitric oxide (NO), factors known to play a key role in the outcome of T. cruzi infection. We show that the protection obtained against the acute T. cruzi infection was surprisingly associated with reduced circulating levels of IL-18 and NO, whereas the release of IL-12p40 was enhanced in comparison to non-vaccinated infected animals. IL-12p35 remained undetectable in infected animals, vaccinated or not. The balance between sTNFR and TNF suggested a decrease of TNF bioactivity in vaccinated mice. These results show that the protection induced by the vaccination with T. rangeli against a challenging infection with T. cruzi is not associated with the strong type 1 immune response usually involved in the control of intracellular pathogens, particularly questioning the protective role of NO during the acute phase of T. cruzi infection.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cytokines,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-12,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-18,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide,
http://linkedlifedata.com/resource/pubmed/chemical/Protozoan Vaccines,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0264-410X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
7
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1868-72
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15121297-Animals,
pubmed-meshheading:15121297-Chagas Disease,
pubmed-meshheading:15121297-Cytokines,
pubmed-meshheading:15121297-Interleukin-12,
pubmed-meshheading:15121297-Interleukin-18,
pubmed-meshheading:15121297-Mice,
pubmed-meshheading:15121297-Mice, Inbred BALB C,
pubmed-meshheading:15121297-Nitric Oxide,
pubmed-meshheading:15121297-Protozoan Vaccines,
pubmed-meshheading:15121297-Receptors, Tumor Necrosis Factor,
pubmed-meshheading:15121297-Survival Analysis,
pubmed-meshheading:15121297-Trypanosoma,
pubmed-meshheading:15121297-Trypanosoma cruzi,
pubmed-meshheading:15121297-Tumor Necrosis Factor-alpha,
pubmed-meshheading:15121297-Vaccination
|
pubmed:year |
2004
|
pubmed:articleTitle |
Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice.
|
pubmed:affiliation |
Facultad de Ciencias Médicas, Universidad Nacional de Córdoba y Servicio Nacional de Chagas, Córdoba, Argentina.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|